{"id":381094,"date":"2020-11-13T16:08:35","date_gmt":"2020-11-13T21:08:35","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=381094"},"modified":"2020-11-13T16:08:35","modified_gmt":"2020-11-13T21:08:35","slug":"biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/","title":{"rendered":"BIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n FOOTHILL RANCH, Calif.<\/span>, Nov. 13, 2020<\/span> \/PRNewswire\/ —\u00a0BIOLASE, Inc.<\/a>\u00a0(NASDAQ: BIOL), the global leader in dental lasers,\u00a0today announced it has been invited to participate in the Benchmark Company Discovery One on One Investor Conference on November 18, 2020<\/span>. President and CEO Todd Norbe<\/span> and Executive Vice President, CFO and COO John Beaver\u00a0will<\/span> hold virtual meetings with institutional investors throughout the day. <\/p>\n

\n

\n
\n \"BIOLASE
\n <\/a>\n <\/p>\n<\/p><\/div>\n

For additional information or to\u00a0schedule a virtual meeting with BIOLASE, please contact your Benchmark representative, or the EVC Group, LLC, BIOLASE’s investor relations firm.<\/p>\n

\n About\u00a0BIOLASE, Inc.<\/b>\n <\/p>\n

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine.\u00a0BIOLASE’s products advance the practice of dentistry and medicine for patients and healthcare professionals.\u00a0BIOLASE’s\u00a0proprietary laser products incorporate approximately 259 patented and 41 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times.\u00a0 BIOLASE’s\u00a0innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE’s\u00a0principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications.\u00a0BIOLASE\u00a0has sold over 41,500 laser systems to date in over 80 countries around the world.\u00a0Laser products under development address\u00a0BIOLASE’s\u00a0core dental market and other adjacent medical and consumer applications.<\/p>\n

For updates and information on Waterlase iPlus\u00ae, Waterlase Express\u2122, and laser dentistry, find\u00a0BIOLASE\u00a0online at\u00a0www.biolase.com<\/a>,\u00a0Facebook\u00a0at\u00a0www.facebook.com\/biolase<\/a>, Twitter at\u00a0www.twitter.com\/biolaseinc<\/a>,\u00a0Instagram at\u00a0www.instagram.com\/waterlase_laserdentistry<\/a>, and LinkedIn at\u00a0www.linkedin.com\/company\/biolase<\/a>.<\/p>\n

BIOLASE\u00ae, Waterlase\u00ae and Waterlase iPlus\u00ae are registered trademarks of\u00a0BIOLASE, Inc.<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020-301172969.html<\/a><\/p>\n

SOURCE BIOLASE, Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire FOOTHILL RANCH, Calif., Nov. 13, 2020 \/PRNewswire\/ —\u00a0BIOLASE, Inc.\u00a0(NASDAQ: BIOL), the global leader in dental lasers,\u00a0today announced it has been invited to participate in the Benchmark Company Discovery One on One Investor Conference on November 18, 2020. President and CEO Todd Norbe and Executive Vice President, CFO and COO John Beaver\u00a0will hold virtual meetings with institutional investors throughout the day. For additional information or to\u00a0schedule a virtual meeting with BIOLASE, please contact your Benchmark representative, or the EVC Group, LLC, BIOLASE’s investor relations firm. About\u00a0BIOLASE, Inc. BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine.\u00a0BIOLASE’s products advance the practice of dentistry and medicine for patients and healthcare professionals.\u00a0BIOLASE’s\u00a0proprietary laser … <\/p>\n

Continue reading “BIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-381094","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire FOOTHILL RANCH, Calif., Nov. 13, 2020 \/PRNewswire\/ —\u00a0BIOLASE, Inc.\u00a0(NASDAQ: BIOL), the global leader in dental lasers,\u00a0today announced it has been invited to participate in the Benchmark Company Discovery One on One Investor Conference on November 18, 2020. President and CEO Todd Norbe and Executive Vice President, CFO and COO John Beaver\u00a0will hold virtual meetings with institutional investors throughout the day. For additional information or to\u00a0schedule a virtual meeting with BIOLASE, please contact your Benchmark representative, or the EVC Group, LLC, BIOLASE’s investor relations firm. About\u00a0BIOLASE, Inc. BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine.\u00a0BIOLASE’s products advance the practice of dentistry and medicine for patients and healthcare professionals.\u00a0BIOLASE’s\u00a0proprietary laser … Continue reading "BIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-13T21:08:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/700996\/BIOLASE_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020\",\"datePublished\":\"2020-11-13T21:08:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\\\/\"},\"wordCount\":306,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/700996\\\/BIOLASE_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\\\/\",\"name\":\"BIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/700996\\\/BIOLASE_Logo.jpg\",\"datePublished\":\"2020-11-13T21:08:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/700996\\\/BIOLASE_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/700996\\\/BIOLASE_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/","og_locale":"en_US","og_type":"article","og_title":"BIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020 - Market Newsdesk","og_description":"PR Newswire FOOTHILL RANCH, Calif., Nov. 13, 2020 \/PRNewswire\/ —\u00a0BIOLASE, Inc.\u00a0(NASDAQ: BIOL), the global leader in dental lasers,\u00a0today announced it has been invited to participate in the Benchmark Company Discovery One on One Investor Conference on November 18, 2020. President and CEO Todd Norbe and Executive Vice President, CFO and COO John Beaver\u00a0will hold virtual meetings with institutional investors throughout the day. For additional information or to\u00a0schedule a virtual meeting with BIOLASE, please contact your Benchmark representative, or the EVC Group, LLC, BIOLASE’s investor relations firm. About\u00a0BIOLASE, Inc. BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine.\u00a0BIOLASE’s products advance the practice of dentistry and medicine for patients and healthcare professionals.\u00a0BIOLASE’s\u00a0proprietary laser … Continue reading \"BIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-13T21:08:35+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/700996\/BIOLASE_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020","datePublished":"2020-11-13T21:08:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/"},"wordCount":306,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/700996\/BIOLASE_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/","name":"BIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/700996\/BIOLASE_Logo.jpg","datePublished":"2020-11-13T21:08:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/700996\/BIOLASE_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/700996\/BIOLASE_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=381094"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381094\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=381094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=381094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=381094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}